AWA
GSK icon

Aaron Wealth Advisors’s GSK GSK Stock Holding History

Aaron Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
31,870
+1,603
+5% +$84.8K 0.08% 153
2026
Q1 		$1.67M Buy
30,267
+4,435
+17% +$240K 0.09% 131
2025
Q4 		$1.27M Buy
25,832
+5,044
+24% +$235K 0.07% 200
2025
Q3 		$897K Sell
20,788
-1,765
-8% -$68.9K 0.05% 259
2025
Q2 		$866K Buy
22,553
+1,183
+6% +$45.2K 0.09% 149
2025
Q1 		$828K Buy
21,370
+1,084
+5% +$39.7K 0.09% 143
2024
Q4 		$686K Sell
20,286
-425
-2% -$15.3K 0.08% 154
2024
Q3 		$847K Buy
20,711
+2,103
+11% +$86K 0.1% 130
2024
Q2 		$716K Buy
18,608
+1,951
+12% +$82.1K 0.1% 133
2024
Q1 		$714K Buy
16,657
+4,446
+36% +$183K 0.1% 124
2023
Q4 		$453K Buy
12,211
+113
+0.9% +$4.06K 0.08% 143
2023
Q3 		$439K Buy
12,098
+637
+6% +$22.6K 0.06% 162
2023
Q2 		$408K Buy
11,461
+616
+6% +$22.1K 0.05% 176
2023
Q1 		$386K Buy
10,845
+886
+9% +$31K 0.05% 175
2022
Q4 		$350K Buy
+9,959
New +$332K 0.05% 180
2022
Q3 		– Sell
-10,654
Closed -$579K – 234
2022
Q2 		$579K Sell
10,654
-426,514
-98% -$23.5M 0.15% 94
2022
Q1 		$12.5M Buy
437,168
+426,806
+4,119% +$23.2M 0.17% 62
2021
Q4 		$571K Buy
10,362
+477
+5% +$24.8K 0.16% 87
2021
Q3 		$472K Buy
9,885
+1,303
+15% +$65.4K 0.13% 95
2021
Q2 		$427K Buy
8,582
+156
+2% +$7.5K 0.14% 102
2021
Q1 		$375K Sell
8,426
-413
-5% -$18.7K 0.14% 103
2020
Q4 		$406K Buy
+8,839
New +$406K 0.15% 89

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aaron Wealth Advisors's GSK Position: Q2 2026 in Review

Aaron Wealth Advisors increased its GSK (GSK) stake by 5.3% in Q2 2026, buying an estimated $84.8K and bringing the position to 31,870 shares worth $1.67M. The position accounts for 0.08% of the portfolio, ranked #153.

Aaron Wealth Advisors first reported a position in GSK in Q4 2020 and has held it in 22 quarters since. The position peaked at $12.5M in Q1 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Aaron Wealth Advisors held 31,870 shares of GSK worth $1.67M as of Q2 2026.
  • Aaron Wealth Advisors bought 1,603 GSK shares in Q2 2026, an estimated $84.8K.
  • GSK made up 0.08% of Aaron Wealth Advisors's portfolio in Q2 2026, its #153 holding.
  • Aaron Wealth Advisors first reported a position in GSK in Q4 2020 and has held it in 22 quarters since.
  • Aaron Wealth Advisors's GSK position peaked at $12.5M in Q1 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.